Dimethylformamide → N1-(4-Difluoromethoxybenzoyl)-N2-[1-(4-pyridyl)piperidin-4-ylmethoxycarbonyl]-1,2-benzenediamine Hydrochloride

HRID 427669

반응식

HRID 427669 반응식
N1C=CC([N:7]2[CH2:12][CH2:11][CH:10]([CH2:13][O:14][C:15]([NH:17][C:18]3[C:19]([NH2:24])=[CH:20][CH:21]=[CH:22][CH:23]=3)=[O:16])[CH2:9][CH2:8]2)=CC=1.[F:25][CH:26]([F:37])[O:27][C:28]1[CH:36]=[CH:35][C:31]([C:32]([OH:34])=O)=[CH:30][CH:29]=1.[ClH:38].CN(C)[CH2:41][CH2:42][CH2:43][N:44]=[C:45]=NCC.[CH3:50]N(C=O)C>>[ClH:38].[F:37][CH:26]([F:25])[O:27][C:28]1[CH:29]=[CH:30][C:31]([C:32]([NH:24][C:19]2[C:18]([NH:17][C:15]([O:14][CH:13]([CH:10]3[CH2:9][CH2:8][NH:7][CH2:12][CH2:11]3)[C:41]3[CH:42]=[CH:43][N:44]=[CH:45][CH:50]=3)=[O:16])=[CH:23][CH:22]=[CH:21][CH:20]=2)=[O:34])=[CH:35][CH:36]=1

참가 물질

5

실험 절차

To a solution of N1-[1-(4-pyridyl)piperidin-4-yl-methoxycarbonyl]-1,2-benzenediamine (0.2 g, 0.6 mmol) and 4-difluoromethoxybenzoic acid (0.23 g, 1.2 mmol) in DMF (10 mL) was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.24 g, 1.2 mmol). After stirring overnight, the solvent was removed in vacuo and the residue was partitioned between ethyl acetate (300 mL) and 1 N NaOH (150 ml). The layers were separated and the organic phase was washed with brine, dried with MgSO4, filtered and concentrated in vacuo. The residue was purified by RPHPLC method A and the fractions containing pure product were combined and lypholized to give 123 mg (38%) of the title product as a white solid.

후처리

  1. customthe solvent was removed in vacuo
  2. customthe residue was partitioned between ethyl acetate (300 mL) and 1 N NaOH (150 ml)
  3. customThe layers were separated
  4. washthe organic phase was washed with brine
  5. dry with materialdried with MgSO4
  6. filtrationfiltered
  7. concentrationconcentrated in vacuo
  8. customThe residue was purified by RPHPLC method A
  9. additionthe fractions containing pure product

출처 및 근거

ORD 기록
ord-ede4f5886f7c4bdca988094cfef1c0e2
출처 데이터셋
uspto-grants-2001_11
특허 번호
US06313122B1

연결된 노트

불러오는 중…